Host defense functions of M. tuberculosis lipoglycan
Host defense functions of M. tuberculosis lipoglycan
批准号:
6371131
负责人:
EDWARD D CHAN
金额:
$22.14万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-07-15 至 2006-05-31
关键词:
Mycobacterium tuberculosis arabinose cell wall clinical research enzyme activity gene induction /repression host organism interaction human subject immunogenetics laboratory mouse macrophage mannans microorganism immunology mitogen activated protein kinase nitric oxide synthase nuclear factor kappa beta receptor tuberculosis tumor necrosis factor alpha
中文摘要
描述(改编自申请人的摘要):结核病(TB)是
传染性病原体导致的主要死亡原因宏观经济发挥着关键作用
通过表达一氧化氮来控制结核分枝杆菌
氧化物(NO.)和TNF α。NO在小鼠体内具有重要的杀菌作用
越来越多的人认识到结核病对人类的重要性。整体
该建议的假设是巨噬细胞通过比表面
受体,识别分枝杆菌细胞壁产物以启动iNOS-和
TNF α诱导。因此,本建议的重点是:
受体和信号传导机制,调节iNOS和TNF α,
暴露于分枝杆菌细胞壁组分脂阿拉伯甘露聚糖(ManLAM)
以及ii)确定这些分量中的每一个在一个
体外感染模型。基于实验表明,
Toll样受体4(TLR 4)突变C3 H/HeJ小鼠产生显着的
响应IFNg +,NO水平低于TLR 4-完整的C3 H/HeN巨噬细胞
ManLAM,我们假设ManLAM与TLR结合以诱导iNOS-NO*/TNF α,
表情由于非甘露糖封端的LAM(AraLAM)来自M.磺胺嘧啶诱导的
比ManLAM更大的NO表达,我们假设ii)暴露的
ManLAM或AraLAM上的阿拉伯糖残基是ManLAM的组分,
其假定的TLR。因为最初的研究表明,
蛋白激酶(MAPKs)和NF κ B信号通路调节iNOS和TNF α
表达,我们假设近端激酶MAP/ERK激酶激酶
MEKK是ManLAM诱导iNOS和TNF α的关键调节因子。最后,
由于TLR识别病原体衍生的分子并增强宿主防御,
假设阻断一个或多个TLR将增强M的生长。
抑制NO* 和TNF α的表达。这些假设将是
有三个具体目标:1。为了确定ManLAM结构,
介导iNOS-NO*/TNF α的诱导以及介导这些的受体
ManLAM效应。2.探讨MAPK和NF κ B信号通路在细胞凋亡中的作用,
在ManLAM-和其他脂聚糖诱导的iNOS-NO* 和TNF α途径中。3.到
阐明TLR、MAPK和NFkB信号通路以及ManLAM在
控制M.小鼠和人巨噬细胞中的结核病,
将对生长的影响与NO* 和TNF α表达相关联。
英文摘要
DESCRIPTION (Adapted from the Applicant's Abstract): Tuberculosis (TB) is the
leading cause of death by an infectious agent. Macrophages play a pivotal role
in the control of Mycobacterium tuberculosis through the expression of nitric
oxide (NO.) and TNFalpha. NO plays an important mycobactericidal role in murine
TB and is increasingly recognized to be important in humans. The overall
hypothesis of this proposal is that macrophages, by specific surface
receptor(s), recognize mycobacterial cell wall products to initiate iNOS- and
TNFa-induction. Hence, the focus of this proposal is to: i) determine the
receptor and signaling mechanisms which regulate iNOS and TNFa following
exposure to the mycobacterial cell wall component lipoarabinomannan (ManLAM)
and ii) to determine the significance of each of these components in an in
vitro model of infection. Based on experiments showing that macrophages from
the Toll-like receptor 4 (TLR4)-mutant C3H/HeJ mice produced significantly
lower levels of NO than TLR4-intact C3H/HeN macrophages in response to IFNg +
ManLAM, we hypothesize that ManLAM engages a TLR to induce iNOS-NO*/ TNFa
expression. Since non-mannose capped LAM (AraLAM) from M. smegmatis induced
greater NO about expression than ManLAM, we hypothesize that ii) the exposed
arabinose residues on ManLAM or AraLAM are the components of ManLAM that bind
to its putative TLR. Since initial studies show that the mitogen-activated
protein kinases (MAPKs) and NFkB signaling pathways regulate iNOS and TNFa
expression, we hypothesize that the proximal kinase MAP/ERK kinase kinase
(MEKK) is a pivotal regulator for ManLAM-induction of iNOS and TNFa. Lastly,
because TLRs recognize pathogen-derived molecules and enhance host-defenses, we
hypothesize that blocking one or more of the TLRs will enhance the growth of M.
tuberculosis and inhibit NO* and TNFa expression. These hypotheses will be
addressed by three specific aims: 1. To determine the ManLAM structures that
mediate the induction of iNOS-NO*/TNFa and the receptor that mediates these
ManLAM effects. 2. To investigate the role of the MAPK and NFkB signaling
pathways in ManLAM- and other lipoglycan-induced iNOS-NO* and TNFa. 3. To
elucidate the role of the TLRs, MAPK and NFkB signaling pathways, and ManLAM in
controlling the growth of M. tuberculosis in mouse and human macrophages and to
correlate effects on growth with NO* and TNFa expression.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Establishing the Therapeutic Efficacy of Alpha-1-Antitrypsin and Enoxaparin Against COVID-19
-
批准号:10588400
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2023
-
负责人:EDWARD D CHAN
-
依托单位:
How Does Nicotine Impair Macrophage Killing of Mycobacterium Tuberculosis?
-
批准号:10060736
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2017
-
负责人:EDWARD D CHAN
-
依托单位:
The role of T regulatory cells in cigarette smoke-induced susceptibility to tuberculosis
-
批准号:9295969
-
项目类别:
-
资助金额:$12.14万
-
财政年份:2016
-
负责人:EDWARD D CHAN
-
依托单位:
Mechanistic study of the host defense functions of IL-32 in tuberculosis
-
批准号:8244621
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:EDWARD D CHAN
-
依托单位:
Mechanistic study of the host defense functions of IL-32 in tuberculosis
-
批准号:8762407
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:EDWARD D CHAN
-
依托单位:
Mechanistic study of the host defense functions of IL-32 in tuberculosis
-
批准号:8422876
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:EDWARD D CHAN
-
依托单位:
Host defense functions of M. tuberculosis lipoglycan
-
批准号:6537916
-
项目类别:
-
资助金额:$30.42万
-
财政年份:2001
-
负责人:EDWARD D CHAN
-
依托单位:
Host defense functions of M. tuberculosis lipoglycan
-
批准号:6902571
-
项目类别:
-
资助金额:$30.42万
-
财政年份:2001
-
负责人:EDWARD D CHAN
-
依托单位:
Host defense functions of M. tuberculosis lipoglycan
-
批准号:6648381
-
项目类别:
-
资助金额:$30.42万
-
财政年份:2001
-
负责人:EDWARD D CHAN
-
依托单位:
Host defense functions of M. tuberculosis lipoglycan
-
批准号:6758005
-
项目类别:
-
资助金额:$30.42万
-
财政年份:2001
-
负责人:EDWARD D CHAN
-
依托单位:
REGULATION OF INSULIN LIKE GROWTH FACTOR I
-
批准号:2027142
-
项目类别:
-
资助金额:$8.15万
-
财政年份:1997
-
负责人:EDWARD D CHAN
-
依托单位:
REGULATION OF INSULIN LIKE GROWTH FACTOR I
-
批准号:2635037
-
项目类别:
-
资助金额:$8.15万
-
财政年份:1997
-
负责人:EDWARD D CHAN
-
依托单位:
REGULATION OF INSULIN LIKE GROWTH FACTOR I
-
批准号:6343288
-
项目类别:
-
资助金额:$11.26万
-
财政年份:1997
-
负责人:EDWARD D CHAN
-
依托单位:
REGULATION OF INSULIN LIKE GROWTH FACTOR I
-
批准号:6138912
-
项目类别:
-
资助金额:$11.26万
-
财政年份:1997
-
负责人:EDWARD D CHAN
-
依托单位:
REGULATION OF INSULIN LIKE GROWTH FACTOR I
-
批准号:2857549
-
项目类别:
-
资助金额:$11.26万
-
财政年份:1997
-
负责人:EDWARD D CHAN
-
依托单位:
海外基金